维普中文期刊产品整合服务
49篇 您的检索式:作者名="Harald C"
    题名 作者 年代 出处 被引量
1Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria显示文摘Bruno Dubois Howard H Feldman Claudia Jacova Harald Hampel José Luis Molinuevo Kaj Blennow Steven T DeKosky Serge Gauthier Dennis Selkoe Randall Bateman Stefano Cappa Sebastian Crutch Sebastiaan Engelborghs Giovanni B Frisoni Nick C Fox Douglas Galasko Ma 2014Lancet Neurology2014,,6:7
2Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults显示文摘Inflammatory bowel diseases(IBDs) are a group of chronic inflammatory conditions mainly of the colon and small intestine. Crohn's disease(CD) and ulcerative colitis(UC) are the most frequent types of IBD. IBD is a complex disease which arises as a result of the interaction of environmental, genetic and immunological factors. It is increasingly thought that alterations of immunological reactions of the patients to their own enterable bacteria(microfilm) may contribute to inflammation. It is characterized by mucosal and sub mucosal inflammation, perpetuated by infiltration of activated leukocytes. CD may affect the whole gastrointestinal tract while UC only attacks the large intestine. The therapeutic goal is to achieve a steroidfree long lasting remission in both entities. UC has the possibility to be cured by a total colectomy, while CD never can be cured by any operation. A lifelong intake of drugs is mostly necessary and essential. Medical treatment of IBD has to be individualized to each patient and usually starts with anti-inflammatory drugs. The choice what kind of drugs and what route administered(oral, rectal, intravenous) depends on factors including the type, the localization, and severity of the patient's disease. IBD may require immune-suppression to control symptoms such as prednisolone, thiopurines, calcineurin or sometimes folic acid inhibitors or biologics like TNF-α inhibitors or anti-integrin antibodies. For both types of disease(CD, UC) the same drugs are available but they differ in their preference in efficacy between CD and UC as 5-aminosalicylic acid for UC or budesonide for ileocecal CD. As therapeutic alternative the main mediators of the disease, namely the activated pro-inflammatory cytokine producing leukocytes can be selectively removed via two apheresis systems(Adacolumn and Cellsorba) in steroid-refractory or dependent cases. Extracorporeal photopheresis results in an increase of regulatory B cells, regulatory CD8^+ T cells and T-regs Type 1. Both types of apheresis were able to induce clinical remission and mucosal healing accompanied by tapering of steroids.Gerda C Leitner Harald Vogelsang 2016World Journal of Gastrointestinal Pharmacology and Therapeutics2016,7,1:3
3Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial显示文摘Caroline AH Klazen Paul NM Lohle Jolanda de Vries Frits H Jansen Alexander V Tielbeek Marion C Blonk Alexander Venmans Willem Jan J van Rooij Marinus C Schoemaker Job R Juttmann Tjoen H Lo Harald JJ Verhaar Yolanda van der Graaf Kaspar J van Everdingen Al 20102010 (9746)2010,,9746:2
4The future of Mzheimer' s disease:The next 10 years显示文摘Harald Hampel David Prvulovi C Stefan Teipel 2011Progress in Neurobiolo- -2011,95,4:1
5Performance anal-ysis of CCSDS File Delivery Protocoland Erasure CodingTechniques in Deep Space Environments显示文摘TOMASO C HARALD E MARIO M 2007ComputerNetworks2007,51,14:1
6Amber force-field parameters for phosphorylated amino acids in different protonation states:phosphoserine,phosphothreonine,phosphotyrosine,and phosphohistidine显示文摘NADINE H ANSELM C H HARALD L 2006Journal of Molecular Modeling2006,12,3:1
7Influence of growth condition on biofilm development and mass transfer at the bulk/biofilm interface显示文摘STEFAN HARALD DIETMAR C 2002Water Research2002,36,:1
8Polyphenols and glutathione synthesis regulation显示文摘Jan MΦ Harald C Mari CWM 2005Am J Clin Nutr2005,81,1:1
9High tempera- ture smart-cut SO1 pressure sensor显示文摘GUO S W HARALD E KIMIKO C 2009Sensors and Actua-tors: A2009,154,2:1
10Characterization of mtDNA SNP typing and mixture ratio assessment with simultaneous real-time PCR quantification of both allelic states 显示文摘Harald N Michael D C Petra G 2006Int J Leg Med2006,120,:1
11Platelets and neurovascular inflammation显示文摘Harald FL Triantafyllos C 2013Thromb Haemost2013,110,2:1
12Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial显示文摘Caroline AH Klazen Paul NM Lohle Jolanda de Vries Frits H Jansen Alexander V Tielbeek Marion C Blonk Alexander Venmans Willem Jan J van Rooij Marinus C Schoemaker Job R Juttmann Tjoen H Lo Harald JJ Verhaar Yolanda van der Graaf Kaspar J van Everdingen Al 2010The Lancet2010,,9746:1
13PPAR activators as antiinflammatory mediators in human T lymphocytes : implications for atherosclerosis and transplantation-associated arteriosclerosis 显示文摘Marx N Debard C Harald S 2002Circ Res2002,90,:1
14Technical calcium nitrate as set accelerator for cement at low temperatures显示文摘HARALD J NYGAARD ERIK C 1995Cement and Concrete Research1995,25,8:1
15Computerized Control of the VOD Process With the Application of a Mass Spectrometer 显示文摘Alok C Cerhard B Harald S 1988Metallurgical Plant and Technology1988,,5:1
16Mild cognitive impairment显示文摘Serge Gauthier Barry Reisberg Michael Zaudig Ronald C Petersen Karen Ritchie Karl Broich Sylvie Belleville Henry Brodaty David Bennett Howard Chertkow Jeffrey L Cummings Mony de Leon Howard Feldman Mary Ganguli Harald Hampel Philip Scheltens Mary C Tierne 2006The Lancet . 2006 (9518)2006,,:1
17Strong in vivo activation of NF-κB in mouse lenses by classic stressors显示文摘George A Harald C Rune B 2003Investigative Oph- Thalmology and Visual Science2003,44,6:1
18Mild cognitive impairment显示文摘Serge Gauthier Barry Reisberg Michael Zaudig Ronald C Petersen Karen Ritchie Karl Broich Sylvie Belleville Henry Brodaty David Bennett Howard Chertkow Jeffrey L Cummings Mony de Leon Howard Feldman Mary Ganguli Harald Hampel Philip Scheltens Mary C Tierne 2006The Lancet2006,,9518:1
19The Safety and Effectiveness of Remifentanil as an Adjunct Sedative for Regional Anesthesia显示文摘MARYLIN L FREDERIC C HARALD B R 1999Anesth Analg1999,88,1:1
20Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a显示文摘Harald Hofer Hans C Bankl Friedrich Wrba Petra Steindl-Munda Markus Peck-Radosavljevic Christoph ?sterreicher Christian Mueller Alfred Gangl Peter Ferenci 2002The American Journal of Gastroenterology2002,,11:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费